Teprotumumab (Anti-IGF-1R / CD221)
Teprotumumab (Anti-IGF-1R / CD221) is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab binds to the ligand binding extracellular α-subunit domain of IGF-1R. Teprotumumab inhibits TSH and IGF-1 action in fibrocytes. Teprotumumab can be used for thyroid-associated ophthalmopathy research.MW: 145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2455 |
Sku # | A2455-1mg |
Pricing | 1mg, $270.00 |